ALNY Financials
Alnylam Pharmaceuticals Inc - Financial statements & key metrics
Stock Price
$240.88
Market Cap
$40.46B
P/E Ratio
1236.4
EPS
$0.30
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$2.25B
Gross Profit
-
Operating Income
-
Net Income
$-278.16M
EPS (Diluted)
$-2.18
Balance Sheet Highlights
Total Assets
$4.24B
Total Liabilities
$4.17B
Shareholders Equity
-
Cash & Equivalents
$966.43M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-8.31M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Operating Margin
29.5%
Net Margin
1.4%
ROE
32.7%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is ALNY revenue?
ALNY's most recent quarterly revenue was $2.25B. Annual revenue can be calculated by summing the four most recent quarters.
Is ALNY profitable?
ALNY reported a loss of $278.16M in the most recent quarter. The net profit margin is 1.4%.
What is ALNY market cap?
ALNY has a market capitalization of $40.46B, making it a large-cap stock.
Does ALNY have debt?
View ALNY's balance sheet for debt information.
What is ALNY cash flow?
Cash flow data is available in the full financial statements.